没有机会别瞎准备
Lv11
40 积分
2024-03-06 加入
-
Pegcetacoplan versus eculizumab in patients with paroxysmal nocturnal haemoglobinuria (PEGASUS): 48-week follow-up of a randomised, open-label, phase 3, active-comparator, controlled trial
1小时前
已完结
-
A Pathologist’s Perspective on Emerging Genomic Tests for Breast Cancer
2小时前
已完结
-
Complement Inhibitors in the Management of Complement-Mediated Hemolytic Uremic Syndrome and Paroxysmal Nocturnal Hemoglobinuria
2小时前
已完结
-
Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial
2小时前
已完结
-
A population-based study of Helicobacter pylori: Does asymptomatic infection mean no gastroscopic lesions?
1个月前
已完结
-
Multicentre real-world data of ramucirumab plus docetaxel after combined platinum-based chemotherapy with programmed death-1 blockade in advanced non-small cell lung cancer: NEJ051 (REACTIVE study)
1个月前
已完结
-
Air pollution and risk of sarcopenia: A two-sample Mendelian randomized study
1个月前
已完结
-
Combination atezolizumab, bevacizumab, pemetrexed and carboplatin for metastatic EGFR mutated NSCLC after TKI failure
1个月前
已完结
-
Pyrotinib in Patients with HER2-Amplified Advanced Non–Small Cell Lung Cancer: A Prospective, Multicenter, Single-Arm Trial
1个月前
已完结
-
Vonoprazan is Not Inferior to Proton Pump Inhibitors in Bismuth-containing Quadruple Therapy for Helicobacter pylori Eradication: A Meta-analysis of 10 Studies From East Asia. J Clin Gastroenterol. 2024 Apr 12
2个月前
已完结